MBL Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

MBL Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$202K	Buy	+874	New	+$216K	0.01%	587

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

MBL Wealth's JAZZ Position: Q3 2026 in Review

MBL Wealth opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 874 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #587 among its holdings.

496 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

MBL Wealth held 874 shares of Jazz Pharmaceuticals worth $202K as of Q3 2026.
Jazz Pharmaceuticals was a new MBL Wealth position in Q3 2026.
Jazz Pharmaceuticals made up 0.01% of MBL Wealth's portfolio in Q3 2026, its #587 holding.
496 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.